Kyverna Therapeutics creates curative medicines to alleviate patients from the effects of autoimmune diseases. With more than 80 known autoimmune diseases, no cures, and lackluster treatment options, Kyverna will fill the gap by aiming to successfully apply cell therapy to autoimmunity. Their engineered cells have the potential to address underlying mechanisms of autoimmune disease with additional benefits of improving safety and tolerability by minimizing toxicity associated with current treatments.